WATERTOWN, Mass.--(BUSINESS WIRE)-- Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the ...
Genentech veteran Frank Lee landed at Forma Therapeutics as it aimed to transition from an early discovery and development company to one that was knocking on the door of approvals and ...
WATERTOWN, Mass. & OXFORD, England--(BUSINESS WIRE)--FORMA Therapeutics and the University of Oxford announced today they have entered into a collaboration and license agreement to identify, validate ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback